TFIID, a multisubunit protein comprised of TBP (TATA box-binding prote
in) and TAF(II)s (TBP-associated factors), has a central role in trans
cription initiation at class II promoters. TAF(II)s role as mediators
of regulatory transcription factors, such as pRb and p53, and their in
volvement in signal transduction pathways suggest that some may partic
ipate in the control of cell proliferation and differentiation: theref
ore, they could be considered potential protooncogenes or antioncogene
s. With the aim of starting to analyse these potential roles, we have
determined the genomic position of nine human TAF(II) genes (TAF(II)25
0, TAF(II)135, TAF(II)100, TAF(II)80, TAF(II)55, TAF(II)43, TAF(II)31,
TAF(II)28, TAF(II)20/15) and of two previously unknown sequences rela
ted to TAF(II)250 and TAF(II)31, respectively. Except for those encodi
ng TAF(II)250 and TAF(II)31, these genes are present in a single copy
and, with the exclusion of those for TAF(II)43 and TAF(II)28 (both at
6p21), are localized in different segments of the genome. Indeed, six
of them map to a chromosomal region commonly altered in specific neopl
asias, which defines them as candidates for in oncogenesis. Our experi
ments also that TAF(II) transcripts are synthesized ubiquitously, most
ly at low levels similar to those of TBP. Interestingly, the amount of
the major mRNA species detected by TAF(II)20/15 cDNA is higher, which
suggests that the polypeptide it encodes may also perform functions i
ndependently of TFIID. TAF(II) isoforms, indicated by additional bands
on Northern blots, may play a role in modulation of TFIID function. T
hese data will be useful for analysing variations of TAF(II) mRNA phen
otype during cell proliferation, differentiation and development, both
normal and pathological.